The Chemours Company (CC) vs Stepan Company (SCL)
- The Chemours Company CC 12.82 −7.03%
- Stepan Company SCL 67.71 −4.16%
The Chemours Company and Stepan Company are both Specialty Chemicals companies. The Chemours Company is the larger, with a market value of $1.9B against $1.5B — 1.2× the size. The Chemours Company has negative trailing earnings, so its P/E is not meaningful; Stepan Company trades at 361×. Stepan Company grew revenue faster over the last twelve months: 10.0% against 0.10%. Stepan Company has the higher net margin (0.17% vs −2.64%) and the higher return on invested capital (0.96% vs 0.44%). Both pay a dividend; The Chemours Company yields more (2.73% vs 2.33%). Across the 22 metrics below, Stepan Company leads on 14 and The Chemours Company on 8.
Valuation
Profitability
| Metric | CC | SCL | Specialty Chemicals median |
|---|---|---|---|
| Gross margin | 15.13% | 11.99% | 27.84% |
| Operating margin | 0.39% | 0.95% | 5.64% |
| Net margin | (2.64%) | 0.17% | 4.19% |
| Free cash flow margin | 3.49% | 0.00% | 3.49% |
| Return on equity | (67.54%) | 0.00% | 2.34% |
| Return on assets | (2.07%) | 0.18% | 0.45% |
| Return on invested capital | 0.44% | 0.96% | 3.21% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack